Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case–control study using electronic records-Reference-Cited by-同舟云学术

Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case–control study using electronic records

Published:2015-01-26 Issue:631 Volume:65 Page:e106-e113
ISSN:0960-1643
Container-title:British Journal of General Practice
language:en
Short-container-title:Br J Gen Pract

Author:

Shephard Elizabeth A,Neal Richard D,Rose Peter,Walter Fiona M,Litt Emma J,Hamilton William T

Publisher

Royal College of General Practitioners

Subject

Family Practice

Reference29 articles.

1. Cancer Research UK Myeloma statistics, http://www.cancerresearchuk.org/cancer-info/cancerstats/types/myeloma/?script=true (accessed 09 Dec 2014).

2. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

3. A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

4. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?

5. Cancer Research UK (2012) Myeloma survival statistics, http://www.cancerresearchuk.org/cancer-info/cancerstats/types/myeloma/survival/ (accessed 26 Nov 2014).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring health disparities in diagnosing multiple myeloma;Expert Review of Hematology;2024-08-08

2. Proactive consultation of laboratory medicine increased diagnostic rate of multiple myeloma: One single center’s 12-year experience;Medicine;2024-06-07

3. Determining diagnostic delays in Romanian multiple myeloma patients using the Aarhus statement;Frontiers in Medicine;2024-05-24

4. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services;British Journal of Haematology;2024-01-02

5. Patient-reported symptoms and diagnostic journey in Multiple Myeloma;Frontiers in Oncology;2023-11-30